CBD may affect medications, alertness, liver function, and surgical planning, but there is no universal timeline for stopping every product. Here is what to disclose and why you should contact your surgical team before making a change.
CBD can raise liver enzymes in some people, particularly at higher oral doses or alongside certain medications. This evidence-first guide explains what the findings mean, who should be cautious, which warning signs deserve attention, and what to ask a clinician.
CBD may affect liver enzymes without causing obvious symptoms. Here is what a recent FDA study found, what it does—and does not—prove, and which factors deserve a conversation with your doctor or pharmacist.
CBD does not normally cause the classic high associated with THC, but it may still cause drowsiness or changes in alertness. This evidence-first guide explains when the risk may be higher and why driving, alcohol, medications, and product quality deserve special attention.
A CBD label may make reassuring promises, but a batch-specific Certificate of Analysis provides more useful evidence. Learn the eight checks that can reveal mismatched reports, unclear THC results, missing contaminant screens, and other warning signs.
